Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00127270
Other study ID # CDAR328AUS01
Secondary ID
Status Completed
Phase Phase 4
First received June 30, 2005
Last updated January 23, 2008
Start date May 2005
Est. completion date February 2006

Study information

Verified date January 2008
Source Novartis
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

This study is designed to investigate the efficacy and safety of treatment of overactive bladder with darifenacin administered alone or in conjunction with behavioral modification therapies.


Recruitment information / eligibility

Status Completed
Enrollment 395
Est. completion date February 2006
Est. primary completion date
Accepts healthy volunteers
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Symptoms of overactive bladder

- Capable of independent toileting and completing a micturition diary

- Able to comprehend English and follow study procedures and instructions

Exclusion Criteria:

- Post void residual > 100ml/sec

- Urine flow rate (Qmax) <10ml/sec for males only

Other protocol-defined inclusion/exclusion criteria may apply

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label


Related Conditions & MeSH terms


Intervention

Drug:
Darifenacin
Darifenacin tablets 7,5 mg once daily with the possibility to up-titrate to 15 mg once daily
Darifenacin
Darifenacin tablets 7,5 mg or 15 mg once daily
Behavioral:
Behavioral therapy
Behavioral Modification Programme for symptoms of overactive bladder

Locations

Country Name City State
United States Atlanta Medical Research Institute Alpharetta Georgia
United States Shepard Center Atlanta Georgia
United States Urology Research Options Aurora Colorado
United States South Florida Medical Research Aventura Florida
United States Alabama Research Center Birmingham Alabama
United States Jacobi Medical Center Bronx New York
United States Progressive Clinical Research Centerville Utah
United States South Carolina Clinical Research Center Columbia South Carolina
United States Northeast Urology Research Concord North Carolina
United States Medical Arts Clinic Corsicana Texas
United States UCLA - Urology Sciences Research Foundation Culver City California
United States Radiant Research Dallas Texas
United States Urology Clinics of North Texas Dallas Texas
United States Private Practice Edmond Oklahoma
United States Welborn Clinic Evansville Indiana
United States Deerpath Physicians Group Gurnee Illinois
United States Advances in Health Houston Texas
United States Kelsey Seybold Research Foundation Houston Texas
United States Urology of Indiana Indianapolis Indiana
United States Mississippi Urology Clinical Research Jackson Mississippi
United States Metropolitan Urology Jeffersonville Indiana
United States San Diego Center for Urology Care La Mesa California
United States Orange County Urology Associates Laguna Woods California
United States R/D Clinical Research Lake Jackson Texas
United States Radiant Research Lakewood Washington
United States Lawrenceville Urology Lawrenceville New Jersey
United States Women's Clinic of Lincoln Lincoln Nebraska
United States Atlantic Urology Medical Group Long Beach California
United States Central New York Clinical Research Manlius New York
United States Southern Oregon Health and Wellness Medford Oregon
United States RMD Clinical Research Institute Melrose Park Illinois
United States Doctors for Women Nashville Tennessee
United States Advance Research Institute New Port Richey Florida
United States California Professional Research Newport Beach California
United States Private Practice North Hollywood California
United States Southern Illinois Clinical Research Center O'Fallon Illinois
United States Florida Healthcare Research Ocala Florida
United States Meridian Clinical Research Omaha Nebraska
United States Quality Clinical Research Omaha Nebraska
United States Winter Park Urology Associates Orlando Florida
United States Urologic Surgery Associates Overland Park Kansas
United States Univ. of Pittsburgh Medical Center- Dept of Urology Pittsburg Pennsylvania
United States Research Protocol Management Specialists Pittsburgh Pennsylvania
United States Portland Clinic Portland Oregon
United States Hudson Valley Urology Poughkeepsie New York
United States Pratt Internal Medicine Group Pratt Kansas
United States Multi Specialty Research Associates of NC Raleigh North Carolina
United States Valley Women's Clinic Renton Washington
United States Virginia Urology Richmond Virginia
United States Intermountain Clinical Research Salt Lake City Utah
United States Salt Lake Research Salt Lake City Utah
United States Medical Center for Clinical Research San Diego California
United States Encompass Clinical Research Spring Valley California
United States Springfield Clinic Springfield Illinois
United States Adult and Pediatric Urology St. Cloud Minnesota
United States PPS Clinical Research St. Louis Missouri
United States Washing Univ School of Medicine - Urologic Research Center St. Louis Missouri
United States Cotton-O'Neil Clinic Topeka Kansas
United States Western Clinical Research Torrance California
United States Williamette Women's Health Tualatin Oregon
United States Quality of Life Medical & Research Tucson Arizona
United States East Coast Clinical Research Virginia Beach Virginia
United States Center for Urologic Care Voorhees New Jersey
United States Connecticut Clinical Research Center Waterbury Connecticut
United States Western Urologic Associates Wheat Ridge Colorado
United States Hearthland Research Associates Wichita Kansas
United States Piedmont Medical Research Associates Winston Salem North Carolina

Sponsors (2)

Lead Sponsor Collaborator
Novartis Procter and Gamble

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change from baseline in average number of urinations per patient per day at Week 12
Secondary Change from baseline in average number of urination episodes per patient per day at Week 2, Week 6
Secondary Change from baseline in average number of urge urinary incontinence episodes, urgency episodes, incontinence pads, and nocturnal urinations per day measured at Weeks 2, 6, 12
Secondary Quality of Life (baseline, Week 6, Week 12)
See also
  Status Clinical Trial Phase
Recruiting NCT05534412 - A Practice-Based Intervention To Improve Care for a Diverse Population Of Women With Urinary Incontinence N/A
Recruiting NCT05515198 - Improving Care for Women With Urinary Incontinence (EMPOWER) N/A
Completed NCT04071301 - Collection of Real-life Measurement Data for TENA SmartCare Change Indicator in Subjects With Urinary Incontinence N/A
Completed NCT03623880 - Enhancing Behavioral Treatment for Women With Pelvic Floor Disorders N/A
Recruiting NCT05880862 - Comparative Effectiveness of Initial OAB Treatment Options Among Older Women at High Risk of Falls Early Phase 1
Recruiting NCT04159467 - Effect of Pelvic Floor Muscle Training on Urinary Incontinence Reports in Obese Women Undergoing a Low Calorie Diet N/A
Completed NCT05485922 - Performance of a Single-use Intermittent Micro-hole Zone Catheter N/A
Completed NCT06268782 - The Effectiveness of an Online Exercise Program on Well-being of Postpartum Women N/A
Not yet recruiting NCT03027986 - Evaluation of a Postural Rehabilitation Program Based on Sensory-motor Control in Men With Urinary Incontinence After Prostatectomy N/A
Recruiting NCT02490917 - ACT™ Balloons Versus Artificial Urinary Sphincter (AMS800™) for the Treatment of Female Stress Urinary Incontinence N/A
Enrolling by invitation NCT02529371 - Pre-Marketing Feasibility Evaluation of the UriCap-RM - Urine Collection in Hospitalized Male Patients N/A
Enrolling by invitation NCT02530372 - Feasibility of the UriCap-F for Urine Collection in Hospitalized Women N/A
Completed NCT02338726 - Pelvic Floor Symptoms and Quality of Life in Elderly Women - a Population-based Pilot Study N/A
Completed NCT02549729 - Effect of the Pelvic Floor Training in Postmenopausal Women With or Without Hormonal Therapy N/A
Completed NCT02600676 - Transcutaneous Electric Nerve Stimulation (TENS) in Children With Enuresis N/A
Completed NCT02368262 - Prevalence of Incontinence and Risk Factors in Children With Cerebral Palsy N/A
Completed NCT02239796 - Feasibility Controlled Trial of Tibial Nerve Stimulation for Stroke Related Urinary Incontinence N/A
Completed NCT01942681 - Female Patients With Signs of uRgE and Stress Urinary Incontinence Study of Propiverine Hydrochloride N/A
Recruiting NCT01804153 - Stem Cells Tratment for the Local Feminine Stress Urinary Incontinence Treatment (HULPURO) Phase 1/Phase 2
Completed NCT01520948 - Behavioral Therapy to Treat Urinary Symptoms in Parkinson Disease Phase 3